Solara Active Pharma Sciences Limited (SOLARA) - Total Assets
Based on the latest financial reports, Solara Active Pharma Sciences Limited (SOLARA) holds total assets worth Rs22.93 Billion INR (≈ $248.03 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SOLARA net assets for net asset value and shareholders' equity analysis.
Solara Active Pharma Sciences Limited - Total Assets Trend (2017–2025)
This chart illustrates how Solara Active Pharma Sciences Limited's total assets have evolved over time, based on quarterly financial data.
Solara Active Pharma Sciences Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Solara Active Pharma Sciences Limited's total assets of Rs22.93 Billion consist of 32.7% current assets and 67.4% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs39.50 Million | 0.2% |
| Accounts Receivable | Rs3.27 Billion | 14.6% |
| Inventory | Rs3.18 Billion | 14.2% |
| Property, Plant & Equipment | Rs10.76 Billion | 48.2% |
| Intangible Assets | Rs298.00 Million | 1.3% |
| Goodwill | Rs3.65 Billion | 16.4% |
Asset Composition Trend (2017–2025)
This chart illustrates how Solara Active Pharma Sciences Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Solara Active Pharma Sciences Limited market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Solara Active Pharma Sciences Limited's current assets represent 32.7% of total assets in 2025, a decrease from 100.0% in 2017.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2025, down from 100.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is property, plant & equipment at 48.2% of total assets.
Solara Active Pharma Sciences Limited Competitors by Total Assets
Key competitors of Solara Active Pharma Sciences Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
Solara Active Pharma Sciences Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.92 | 0.72 | 1.42 |
| Quick Ratio | 0.49 | 0.45 | 1.05 |
| Cash Ratio | 0.00 | 0.01 | 0.00 |
| Working Capital | Rs-726.90 Million | Rs-2.89 Billion | Rs3.12 Billion |
Solara Active Pharma Sciences Limited - Advanced Valuation Insights
This section examines the relationship between Solara Active Pharma Sciences Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.87 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -5.1% |
| Total Assets | Rs22.32 Billion |
| Market Capitalization | $193.95 Million USD |
Valuation Analysis
Below Book Valuation: The market values Solara Active Pharma Sciences Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Solara Active Pharma Sciences Limited's assets decreased by 5.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Solara Active Pharma Sciences Limited (2017–2025)
The table below shows the annual total assets of Solara Active Pharma Sciences Limited from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs22.32 Billion ≈ $241.37 Million |
-5.07% |
| 2024-03-31 | Rs23.51 Billion ≈ $254.25 Million |
-18.91% |
| 2023-03-31 | Rs28.99 Billion ≈ $313.52 Million |
-1.81% |
| 2022-03-31 | Rs29.53 Billion ≈ $319.30 Million |
+12.97% |
| 2021-03-31 | Rs26.14 Billion ≈ $282.65 Million |
+21.36% |
| 2020-03-31 | Rs21.54 Billion ≈ $232.89 Million |
+9.87% |
| 2019-03-31 | Rs19.60 Billion ≈ $211.97 Million |
+7.60% |
| 2018-03-31 | Rs18.22 Billion ≈ $196.99 Million |
+18215230.00% |
| 2017-03-31 | Rs100.00K ≈ $1.08K |
-- |
About Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arr… Read more